EDGAR Filing Documents for 0001104659-17-024519

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-17-024519

Filing Date

2017-04-19

Accepted

2017-04-19 16:11:59

Documents

Period of Report

2017-04-19

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	a17-10023_36k.htm	6-K	17331
2	EX-99.1	a17-10023_3ex99d1.htm	EX-99.1	26126
3	EX-99.2	a17-10023_3ex99d2.htm	EX-99.2	87465
4	EX-99.3	a17-10023_3ex99d3.htm	EX-99.3	12944
5	EX-99.4	a17-10023_3ex99d4.htm	EX-99.4	12026
6	EX-99.5	a17-10023_3ex99d5.htm	EX-99.5	908229
7	GRAPHIC	g100233mm07i001.jpg	GRAPHIC	2854
8	GRAPHIC	g100233mm01i001.jpg	GRAPHIC	2854
9	GRAPHIC	g100233mm05i001.jpg	GRAPHIC	2854
10	GRAPHIC	g100233mm03i001.jpg	GRAPHIC	2854
	Complete submission text file	0001104659-17-024519.txt		1081425

Mailing Address ?STERGADE 24A, 1 COPENHAGEN G7 1100

Business Address ?STERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242

Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)